The HRA and MHRA have been exploring opportunities to improve the service being offered for the approval and ongoing management of Clinical Trials of Medicinal Products (CTIMPs) and launched a pilot to test an integrated process – the Combined Ways of Working Pilot.
Quotient Sciences have made a number of submissions through the HRA/MHRA Combined Ways of Working Pilot and we describe our experience of these submissions below:
It’s great to have a more joined up approach from the regulators. The interaction and co-ordination between the REC and the MHRA works really well.
Read further feedback from us on HRA website here.